BIOMAT Database Logo BIOMAT Database Logo

The effect of human plasma on the anticoagulant activity of heparin. 1950

C L CONLEY, and R C HARTMANN, and J S LALLEY

UI MeSH Term Description Entries
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

C L CONLEY, and R C HARTMANN, and J S LALLEY
Postheparin plasma diamine oxidase activity and the anticoagulant effect of heparin.
April 2000, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
C L CONLEY, and R C HARTMANN, and J S LALLEY
Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma.
April 1984, Thrombosis and haemostasis,
C L CONLEY, and R C HARTMANN, and J S LALLEY
Plasma heparin levels. I. A method for determination of plasma heparin based on anticoagulant activity.
May 1954, American journal of clinical pathology,
C L CONLEY, and R C HARTMANN, and J S LALLEY
[Effect of complexes of heparin with plasma proteins on the anticoagulant and fibrinolytic activity of blood].
December 1986, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
C L CONLEY, and R C HARTMANN, and J S LALLEY
Bioengineered human heparin with anticoagulant activity.
November 2016, Metabolic engineering,
C L CONLEY, and R C HARTMANN, and J S LALLEY
THE HEPARIN CO-FACTOR ACTIVITY IN PLASMA AND ITS RELATION TO THE ANTICOAGULANT EFFECT OF INTRAVENOUSLY INJECTED HEPARIN.
August 1963, Acta physiologica Scandinavica,
C L CONLEY, and R C HARTMANN, and J S LALLEY
The effect of heparin on the fibrinolytic activity of streptokinase-activated human plasma.
January 1962, Scandinavian journal of clinical and laboratory investigation,
C L CONLEY, and R C HARTMANN, and J S LALLEY
The effect of heparin on the plasma fibrinolytic activity.
January 1974, Acta physiologica Polonica,
C L CONLEY, and R C HARTMANN, and J S LALLEY
The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin.
January 1996, Journal of biomaterials science. Polymer edition,
C L CONLEY, and R C HARTMANN, and J S LALLEY
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity.
April 1993, Thrombosis research,
Copied contents to your clipboard!